Interleukin 15 (IL-15) is a novel cytokine that has recently been doned and expressed. Whereas it has no sequence homology with IL-2, IL-15 interacts with components of the IL-2 receptor (IL-2R). In the present study we performed a functional analysis of recombinant IL-15 on phenotypically and functionally distinct popttlations of highly purified human natural killer (NK) cells. The CD56 b~ht subset of human NK cells constitutively expresses the high affinity IL-2R and exhibits a brisk proliferative response after the binding of picomolar amounts of IL-2. Using a proliferation assay, IL-15 demonstrated a very steep dose-response curve that was distinct from the dose-response curve for IL-2. The proliferative effects of IL-15 could be abrogated by anti-IL-2R~ (p75), but not by anti-IL-2Rc~ (p55). The proliferative effects of IL-2 on CD56bns ht NK cells could be inhibited by both antibodies. CD56 ~n NK cells express the intermediate affinity IL-2R in the absence of the high affinity IL-2R. Activation of CD56 a~ NK cells by IL-15 was similar to that of IL-2 as measured by enhanced NK cytotoxic activity, antibodydependent cdlular cytotoxicity, and NK cell production of interferon % tumor necrosis factor c~, and granulocyte/macrophage colony-stimulating factor. The IL-15-enhanced NK cytotoxic activity could be completely blocked by anti-IL-21L8 monoclonal antibody. The binding of radiolabded IL-2 and IL-15 to CD56 d~n NK cells was inhibited in the presence of anti-IL-21LB. Scatchard analysis of radiolabeled IL-15 and IL-2 binding to NK-enriched human lymphocytes revealed the presence of high and intermediate affinity receptors for both ligands. IL-15 is a ligand that activates human NK cells through components of the IL-2R in a pattern that is similar but not identical to that of IL-2. Unlike IL-2, IL-15 is produced by activated monocytes/macrophages. The discovery of IL-15 may increase our understanding of how monocytes/macrophages participate in the regulation of NK cell function.
H
uman NK cells are LGL that do not rearrange TCR genes, and demonstrate cytotoxic activity against tumor and viraUy infected cell targets without prior sensitization or MHC restriction. As such, NK cells appear to have an important role in the early defense against viral infection and malignant transformation (for a review see reference 1).
NK cells can be identified phenotypically by the expression of CD56, an isoform of the human neural cell adhesion molecule, as well as CD16 or FcR3,III (1) . Approximately 10% of NK cells have high density expression of CD56 (CD56b~isht). The CD56br~ ht NK cells constitutively express the high affinity heterotrimeric IL-2 receptor (IL-2RoeB'y), as well as the intermediate affinity heterodimeric IL-2RB3; (2, 3) . The more abundant CD56 di~ NK cells constitutively express the intermediate affinity heterodimeric IL-2RB3' (4). IL-2 binding to the high affinity IL-2R expressed on CD56b~g ht NK cells results in a strong proliferative response, whereas complete saturation of the intermediate affinity IL-2R on either CD56b~i# t or CD56 aim NK cells results in enhanced cytotoxic activity with little or no effect of proliferation (2) . Thus, NK cells appear to have relatively distinct functional responses after the binding of IL-2 to the high or intermediate affinity IL-2R.
IL-15 is a novel cytokine that has recently been cloned from the simian kidney epithelial cell line, CV1/EBNA (5) . Whereas the sequence of IL-15 shows no homology with IL-2, IL-15 can bind to a variety of cell lines, human mononuclear cells, and activated T cells. On activated T cells, IL-15 appears to use components of the IL-2tL for binding and signal transduction (5, 6) . In contrast to IL-2, IL-15 appears to be much more abundantly expressed in a wide variety of tissues, inchding phcenta, skeletal muscle, kidney, and activated monocytes/macrophages (5) . Thus, IL-15 may be very important for NK cell function as NK cells are unique among human lymphocytes in their constitutive expression of functional IL-2R. We therefore investigated the functional response of human NK ceUs to IL-15, and compared these responses to those of IL-2.
Materials and Methods
Cytokines. Purified (6) . Binding experiments were carried out at 4~ for I h, with conditions empirically determined to result in saturable binding and reduced rate of internalization of lzsI-II~15 bound to cell surface receptors. Binding experiments were performed using the phthalate oil separation method and data analysis as described by Dower et al. (12) . In each experiment, between 5 • 107 and 1 x 104 resting human NK cells were used. Resting human NK cells were purified by depleting nonadherent PBMC of T cells and B cells with immunomagnetic purging as described above. Cells were between 75 and 90% CD3-CD56 + by FACS | analysis (Becton Dickinson & Co.). In some experiments, depleted cells were again labeled with anti-CD3 mAb and subsequently passed over a magnetic-activated cell sorter (MACS) column (Milentyi Biotec, Sunnyvale, CA), which brought the purity of CD3-CD56 + cells up to 90% by FACS | analysis. Freshly depleted resting NK cells were sent by overnight courier from Buffalo, NY to Seattle, WA on wet ice. Upon arrival, Ib2 and IL-15 binding studies were carfled out as described above. To confirm that overnight shipment had not led to artifactual findings, reagents for isolation of NK cells were sent to Seattle on one occasion and binding studies were performed on freshly isolated NK cells with identical results. high affinity IL-2R (i.e., 0.10 and 1.0 ng/ml). 10 ng/ml of IL-2 afforded full saturation of the high affinity IL-2R and partial saturation of the intermediate affinity IL-2R, and resulted in a maximal proliferative response. Further increases in the concentration of IL-2 to 100 ng/ml fully saturated the intermediate affinity IL-2R expressed on CD56 b~ight NK cells, but did not increase proliferation (2) . In contrast to IL-2, IL-15 did not induce proliferation of CD56 bright NK cells at concentrations ranging from 0.01 to 1.0 ng/ml in over 20 separate experiments. However, at 10 ng/ml, IL-15 produced a maximal proliferative response in CD56b~g ht NK ceils. Thus IL-15 had a much steeper dose-response curve than IL-2 ( Fig. 1 A) . Like IL-2, additional increases in the concentration of IL-15 did not further enhance the proliferative response of CD56b~ig ht NK ceils. In data not shown, the median effective concentration (ECs0) for IL-15 in these CD56b'~g h~ NK proliferation experiments ranged between 3.0 and 7.0 ng/ml (i.e., *0.2 and 0.5 nM), whereas the ECs0 in identical experiments with IL-2 ranged between 0.45 and 0.7 ng/ml (i.e., "~30 and 50 pM).
Results

Effects of IL-15 on
The vast majority of CD56 ~m NK cells constitutively express the intermediate affinity IL-2R (4), and exhibit minimal proliferation in the presence of saturating concentrations of IL-2 (2). As shown in Fig. 1 B, incubation of CD56 ~m NK cells in increasing concentrations of either IL-2 or IL-15 produced very little proliferation relative to the CD56b~ig ht NK cells (Fig. 1 A) .
We next examined the effects of anti-IL-2Ro~ and anti-IL-2RB mAbs on IL-2-and IL-15-induced proliferation in CD56bns h' NK cells. Preincubation of CD56b~ig h~ NK cells with anti-IL-2Rc~ resulted in significant inhibition of IL-2-induced proliferation at concentrations of IL-2 that selectively saturate the high affinity IL-2 receptor (Fig. 1 C) (2, 3) . In contrast, anti-IL-2Rol had no effect on IL-15-indueed prolif~-ation of CD56bng ht NK cells (Fig. 1 D) . Anti-IL-2Rfl mAb inhibited IL-2-induced proliferation of CD56 b~ght NK cells at low concentrations of IL-2 (0.1-10 ng/ml), but could be overcome at higher concentrations of IL-2 ( Fig. 1 E) . Anti-IL-2RB mAb could also inhibit IL-15-induced proliferation of CD56~s ht NK cells at 10 ng/ml, but this could be overcome at lO-fold higher concentrations of IL-15 ( Fig. 1 F) . Thus, whereas IL-2 interacts with both the IL-2Rc~ and IL-2RB components of the IL-2R to induce a proliferative response in CD56b~ig ht NK cells, IL-15 appears to bind to IL-2RB but not IL-2Ret in producing a similar functional response, as shown in other systems (5, 6) .
As shown in Fig. 1 A, an increase in IL-15 concentration from 1 to 10 ng/ml results in CD56bng ht NK cells going from no proliferative response to a maximum proliferative response, respectively. At concentrations of IL-15 between I and 10 ng/ml (i.e., ,v2 ng/ml), a submaximal proliferative response is noted (Fig. 2) . It is important to note that the same proliferative response is produced with IL-2 at approximately lO-fold lower concentrations (i.e., '~0.15 ng/ml of IL-2). Submaximal concentrations of IL-15 can combine with low concentrations of IL-2 to produce an additive proliferative response to CD56bng h~ NK cells, but only before full saturation of the high affinity IL-2R with IL-2, which occurs at 15 ng/ml of IL-2. At that point, the two cytokines are no longer additive (Fig. 2) . Furthermore, when IL-15 induced a maximal proliferative response of the CD56b~ig h' NK cells at 10 ng/ml, combinations with lower concentrations of IL-2 which only saturate the high affinity IL-2R, did not further augment proliferation (data not shown).
Activation of NK Cytotoxic Activity with IL-15. NK cells
display LAK activity against NK-resistant target cells after incubation in concentrations of IL-2 that saturate the intermediate affinity IL-2 receptor (2). This activity can be abrogated in the presence of anti-IL-2RB mAb (13) . Incubation of CD56 a~n NK cells in the presence of IL-15 resulted in LAK activity against the NK-resistant cell line COLO 205 in a dose-dependent fashion (Fig. 3 A) . The IL-2 doseresponse curve was identical to that of IL-15 (data not shown). Like IL-2, IL-15-induced LAK activity was completely abrogated in the presence of anti-IL-2RB mAb (Fig. 3 B) . Thus IL-15 binds to IL-2P,~ to enhance cytotoxic activity of human NK cells. A similar dose-response curve was obtained when NK cells were incubated with increasing concentrations of IL-15 and assayed for ADCC against the P815 murine mastocytoma cell line in the presence of a rabbit anti-mouse antiserum (Fig. 3 C) . IL-12 is known to induce LAK activity in human NK cells, and coincubation of NK ceils with both IL-12 and IL-2 can have an additive effect on NK cytotoxic activity (14, 15) . As can be seen in Fig. 3 D, combinations of IL-12 and IL-15 resulted in additive LAK activity that was nearly identical to that seen with IL-12 and IL-2. However, there was no synergistic or even additive effect on LAK activity when NK calls were incubated with equivalent amounts of IL-2 and 
iiiiiiiiiii IFN-3' production. When IL-12 was combined with either IL-2 or IL-15, significant and nearly equivalent amounts of INF-'), were produced. The same was true of TNF-ol production by NK cells (Fig. 4 B) . However, in repeated experiments, the production of GM-CSF by IL-2-stimulated NK cells was nearly twice that of IL-15-stimulated NK cells. It is important to note that there was no additive production It is important to note that whereas combinations of IL-15 or IL-2 could synergize equally well with IL-12 on CD56 ~m NK cells, illustrating the NK cell's potential to markedly increase cytotoxicity and cytokine production, the combination of IL-15 with IL-2 never produced an additive or synergistic response, but exhibited the same stimulation as either cytokine acting alone. This would imply that for these functions on human CD56 d~ NK calls, IL-15 and IL-2 are mutually redundant (21) . However, the relative abundance of these two cytokines may lend some insight into which combination with IL-12 is likely to be more relevant in vivo. T cells transiently produce IL-2 after antigen activation, and require this cytokine in order to mount a successful immune response (22) . As no other effector cell of the immune system is known to produce IL-2, its availability for NK cell activation via the intermediate affinity IL-2R is likely to be quite limited. In contrast, IL-12 production by activated monocytes/macrophages has been shown to be a critical component of host defense against invading pathogens via its stimulation of NK cell IFN-3' production (for a review see reference 23). As IL-15 is also produced by activated monocytes/macrophages (5), and can synergize with IL-12 in stimulating NK cell IFN-3" production, IL-15 may be the more important ligand for the intermediate affinity IL-2R expressed on human NK cells. The definitive experiments to test this hypothesis await the in vivo administration of neutralizing antibodies directed against IL-15 in animal models. Likewise, it remains to be determined if NK cells themselves can produce IL-15.
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The CD56 brlght NK cells constitutively express both a high affinity and intermediate affinity IL-2K, and in contrast to CD56 d~ NK cells, the proliferative responses to IL-2 and IL-15 were distinct. At concentrations of 0.10 and 1.0 ng/ml of IL-2, a progressive increase in DNA synthesis was noted among the CD56 bqht NK cells, whereas IL-15 showed no evidence of activity at identical concentrations. Previous work (2, 24) has shown that these concentrations of IL-2 result in partial to complete saturation of the heterotrimeric high affinity IL-2RaB3", supported in the present study by the partial inhibition seen in the presence of anti-IL-2Kcr mAb. A 10-fold higher concentration of IL-2 (10 ng/ml) partially saturates the intermediate affinity IL-2R but also provides continual complete saturation of the high affinity IL-2R for the entire period of culture. The latter effect is likely to be responsible for the maximum proliferation noted at this point, as further saturation of the intermediate affinity IL-2K with even higher concentrations of IL-2 does not enhance proliferation (2) .
In distinct contrast to 11,-2, the first CD56bng ht NK proliferative response to IL-15 did not occur until log increases in concentration reached 10 ng/ml. Anti-IL-2ILo~ mAb did not inhibit this response, whereas anti-IL-2Pq8 did. The explanation for the 10-fold difference between the IL-2 and IL-15 dose-response curves for CD56b~g h' NK cell proliferation is not clear at this time, but similar differences have been noted for PHA-activated human T cells (5) . Scatchard analysis of radiolabeled IL-2 and IL-15 binding to unstimulated human NK cells showed that both cytokines identified high and intermediate aflL, fity receptor sites. The high af~nity IL-2R sites were few in number and are likely to represent those expressed by the CD56b~i# ' NK subset (1% of PBL, 10% of NK cells), which is the only cell known to constitutively express high affinity IL-2R in unstimulated PBL (2, 3) . The functional significance of NK cell receptors that bind IL-15 with apparent high aflfinity (K~I of 11.7 pM) and lower aflfinity (KD2 of 500 pM) as shown in Fig. 5 cannot be determined at this time, as radiolabeled ligand binding assays were performed at 4~ whereas biologic responses were assayed at 37~ It is possible that IL-15 uses other receptor components not required for IL-2. Indeed, Grabstein et al. (5) and Girl et al. (6) have identified murine cell lines that proliferate vigorously in response to IL-2, but poorly or not at all to IL-15.
In summary, we have characterized the functional responses of human NK cell subsets to IL-15. IL-15 appears to use components of the IL-2R to induce proliferation, cytotoxic activity, and cytokine production in this subset of lymphocytes. Whereas IL-15 was found to share many biologic properties of IL-2 in this regard, certain properties of IL-15 were distinct from IL-2 in CD56b~ h' NK cells. In animal models, monocyte/macrophage-derived cytokines have been shown to be important in defense against invading pathogens via their regulation of NK cell IFN-'y production (20) . Whereas we and others (25) have shown that IL-2 can potentiate these functions in vitro, the limited production of IL-2 by activated T cell subsets might suggest that this mechanism is not operative in vivo. In distinct contrast to IL-2, IL-15 appears to be abundantly expressed in a variety of tissues and cell types, including activated monocytes/macrophages (5). The constitutive expression of functional IL-2 receptors on human NK cells, and our in vitro demonstration that IL-15 can potentiate NK cell cytokine production and cytotoxic activity in combination with other monocyte/macrophagederived cytokines suggests that this synergy may also be important in vivo. Additional studies with IL-15 should provide further insight into the role of this molecule in normal host immunity.
